Adagene (ADAG) News Today $1.63 -0.01 (-0.37%) Closing price 03:41 PM EasternExtended Trading$1.72 +0.09 (+5.20%) As of 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Adagene And 2 Other Promising Penny Stocks To WatchApril 2 at 5:01 PM | finance.yahoo.comAdagene Reports 33% Overall Response Rate in Phase 2 Expansion of Muzastotug for MSS CRC, Highlights Financial Position and Future MilestonesMarch 26, 2025 | nasdaq.comAdagene (ADAG) Projected to Post Earnings on ThursdayMarch 25, 2025 | americanbankingnews.comAdagene (ADAG) to Release Quarterly Earnings on ThursdayAdagene (NASDAQ:ADAG) will be releasing earnings before the market opens on Thursday, March 27, Financial Modeling Prep reports.March 25, 2025 | marketbeat.comAdagene reports FY24 adjusted EPS (51c), consensus (58c)March 25, 2025 | markets.businessinsider.comAdagene Reports Full Year 2024 Financial Results and Provides Corporate UpdateMarch 25, 2025 | markets.businessinsider.comAdagene Inc. Reports 2024 Financial Results and ProgressMarch 25, 2025 | tipranks.comAdagene Reports 2024 Financial Results and Advances Clinical ProgramsMarch 24, 2025 | tipranks.comAdagene Reports Full Year 2024 Financial Results and Provides Corporate UpdateMarch 24, 2025 | globenewswire.comAdagene Inc. (NASDAQ:ADAG) Short Interest Down 55.9% in FebruaryAdagene Inc. (NASDAQ:ADAG - Get Free Report) was the recipient of a significant decline in short interest in February. As of February 28th, there was short interest totalling 17,700 shares, a decline of 55.9% from the February 13th total of 40,100 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 82,400 shares, the short-interest ratio is currently 0.2 days.March 14, 2025 | marketbeat.comAdagene to Present at 11th Annual Immuno-Oncology 360° SummitMarch 13, 2025 | tmcnet.comAdagene Inc. to Present ADG126 SAFEbody® Data at 11th Annual Immuno-Oncology 360⁰ Summit in BostonMarch 13, 2025 | quiverquant.comAdagene to Present at 11th Annual Immuno-Oncology 360⁰ SummitMarch 13, 2025 | globenewswire.comGeneral Atlantic L.P. Acquires 3,561,952 Shares of Adagene Inc. (NASDAQ:ADAG)General Atlantic L.P. grew its holdings in shares of Adagene Inc. (NASDAQ:ADAG - Free Report) by 1,349.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,825,952 shares of the company's stMarch 11, 2025 | marketbeat.comAdagene (NASDAQ:ADAG) Stock Price Up 0.2% - Still a Buy?Adagene (NASDAQ:ADAG) Trading 0.2% Higher - Here's WhyMarch 8, 2025 | marketbeat.comAdagene to Present at Leerink’s Global Healthcare Conference 2025March 6, 2025 | finance.yahoo.comAdagene to Present at Leerink's Global Healthcare Conference 2025March 6, 2025 | globenewswire.comAdagene begins Phase 2 trial for neoadjuvant muzastotug in colorectal cancerFebruary 28, 2025 | markets.businessinsider.comAdagene Inc. to Initiate Phase 2 Trial of ADG126 for Colorectal Cancer with Enrollment Starting in April 2025February 27, 2025 | quiverquant.comAdagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal CancerFebruary 27, 2025 | globenewswire.comAdagene Inc. (NASDAQ:ADAG) Short Interest UpdateAdagene Inc. (NASDAQ:ADAG - Get Free Report) was the target of a significant decline in short interest in January. As of January 31st, there was short interest totalling 35,400 shares, a decline of 50.2% from the January 15th total of 71,100 shares. Currently, 0.1% of the company's stock are sold short. Based on an average trading volume of 93,700 shares, the days-to-cover ratio is presently 0.4 days.February 13, 2025 | marketbeat.comAdagene (NASDAQ:ADAG) Rating Lowered to Equal Weight at Morgan StanleyMorgan Stanley lowered Adagene from an "overweight" rating to an "equal weight" rating in a research note on Friday.January 31, 2025 | marketbeat.comMorgan Stanley downgrades Adagene (ADAG) to a HoldJanuary 31, 2025 | markets.businessinsider.comAdagene downgraded to Equal Weight from Overweight at Morgan StanleyJanuary 31, 2025 | markets.businessinsider.comAdagene Inc. (NASDAQ:ADAG) Sees Significant Growth in Short InterestAdagene Inc. (NASDAQ:ADAG - Get Free Report) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 79,600 shares, a growth of 21.9% from the December 31st total of 65,300 shares. Based on an average daily trading volume, of 60,400 shares, the days-to-cover ratio is currently 1.3 days. Approximately 0.2% of the company's shares are sold short.January 31, 2025 | marketbeat.comCD47 Inhibitor Drug Clinical Trials Market Opportunity Outlook 2028, Competitive Analysis of Adagene, ALX, ImmuneOncia, ImmuneOnco, Light Chain Bioscience, Phanes, and Virtuoso,January 29, 2025 | globenewswire.comFY2024 Earnings Forecast for Adagene Issued By HC WainwrightAdagene Inc. (NASDAQ:ADAG - Free Report) - Research analysts at HC Wainwright boosted their FY2024 earnings per share (EPS) estimates for Adagene in a research report issued to clients and investors on Monday, January 27th. HC Wainwright analyst A. He now anticipates that the company will earn ($January 29, 2025 | marketbeat.comFY2029 Earnings Estimate for Adagene Issued By HC WainwrightAdagene Inc. (NASDAQ:ADAG - Free Report) - Stock analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for Adagene in a research note issued to investors on Monday, January 27th. HC Wainwright analyst A. He anticipates that the company will post earnings of ($0.56) perJanuary 28, 2025 | marketbeat.comAdagene announces updated data from Phase 1b/2 study of muzastotug, keytrudaJanuary 27, 2025 | markets.businessinsider.comAdagene price target raised to $8 from $5 at H.C. WainwrightJanuary 27, 2025 | msn.comAdagene’s ADG126: Promising Efficacy and Safety Profile Justifies Buy RatingJanuary 27, 2025 | markets.businessinsider.comH.C. Wainwright lifts Adagene stock target to $8 on ASCO dataJanuary 27, 2025 | msn.comAdagene reports positive colorectal cancer trial resultsJanuary 27, 2025 | msn.comHC Wainwright Forecasts Strong Price Appreciation for Adagene (NASDAQ:ADAG) StockHC Wainwright upped their price target on Adagene from $5.00 to $8.00 and gave the company a "buy" rating in a research report on Monday.January 27, 2025 | marketbeat.comAdagene Reports Promising Results in Colorectal Cancer StudyJanuary 27, 2025 | tipranks.comAdagene to present new ADG126 clinical data at ASCO-GIJanuary 21, 2025 | msn.comAdagene Inc. to Present Updated Clinical Data for ADG126 in MSS Colorectal Cancer at ASCO Gastrointestinal Cancers SymposiumJanuary 21, 2025 | quiverquant.comAdagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers SymposiumJanuary 21, 2025 | globenewswire.comAdagene to host virtual KOL event to discuss SAFEbodyADG126January 16, 2025 | markets.businessinsider.comNovember 2024's Top Picks: Penny Stocks On US ExchangesNovember 29, 2024 | uk.finance.yahoo.comAdagene Inc. (NASDAQ:ADAG) Sees Large Decrease in Short InterestAdagene Inc. (NASDAQ:ADAG - Get Free Report) was the recipient of a large decline in short interest in October. As of October 31st, there was short interest totalling 12,300 shares, a decline of 42.5% from the October 15th total of 21,400 shares. Based on an average daily trading volume, of 88,800 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company's stock are short sold.November 13, 2024 | marketbeat.comAdagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Society for Immunotherapy of Cancer (SITC) 39th Annual MeetingNovember 7, 2024 | globenewswire.comCoya stock tumbles 23% on mixed results from Alzheimer's studyOctober 29, 2024 | msn.comAdagene Inc. (NASDAQ:ADAG) Short Interest Down 30.7% in OctoberAdagene Inc. (NASDAQ:ADAG - Get Free Report) was the recipient of a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 21,400 shares, a decrease of 30.7% from the September 30th total of 30,900 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily volume of 75,400 shares, the short-interest ratio is presently 0.3 days.October 27, 2024 | marketbeat.comAdagene And 2 Other US Penny Stocks To ConsiderOctober 22, 2024 | finance.yahoo.comAdagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual MeetingOctober 9, 2024 | globenewswire.comAdagene Inc. to Post FY2024 Earnings of ($0.78) Per Share, HC Wainwright Forecasts (NASDAQ:ADAG)Adagene Inc. (NASDAQ:ADAG - Free Report) - Research analysts at HC Wainwright raised their FY2024 earnings estimates for shares of Adagene in a note issued to investors on Wednesday, September 18th. HC Wainwright analyst A. He now expects that the company will post earnings per share of ($0.78) fSeptember 20, 2024 | marketbeat.comBuy Rating Affirmed on Adagene: Promising ADG126 Clinical Data and Market UnderappreciationSeptember 19, 2024 | markets.businessinsider.comAdagene (NASDAQ:ADAG) Receives Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $5.00 price objective on shares of Adagene in a research note on Wednesday.September 18, 2024 | marketbeat.comAdagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)September 16, 2024 | globenewswire.com Remove Ads Get Adagene News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAG and its competitors with MarketBeat's FREE daily newsletter. Email Address ADAG Media Mentions By Week ADAG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADAG News Sentiment▼0.800.60▲Average Medical News Sentiment ADAG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADAG Articles This Week▼21▲ADAG Articles Average Week Remove Ads Get Adagene News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARCT News Today AQST News Today SLDB News Today GLUE News Today TSHA News Today ESPR News Today TKNO News Today ATAI News Today ATYR News Today CADL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADAG) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADAG Stock Free ADAG Stock Alerts